The company has committed to refraining from additional draws on the ELOC for either 30 trading days or until its share price reaches $10, demonstrating confidence in its near-term business prospects.

The oral administration of a liquid pantoprazole formulation has been previously described. [6] However, the drug is not commercially available as an oral liquid preparation. Because pantoprazole ...

Aspargo Labs uses a proprietary technology platform to reformulate oral medication to liquid doses. CEO and chairman Michael Demurjian spoke with Pharmaceutical Executive about the development of the ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

It is not commercially available in an injectable or oral liquid dosage form. An oral liquid preparation would allow for more accurate dosing for patients, especially children, who may require ...

Ivabradine 1mg/mL; preservative-free. Corlanor (ivabradine) oral solution is a colorless liquid supplied in an opaque, low density polyethylene (LDPE) plastic ampule. Each 5 mL ampule is ...

PAI offers the broadest portfolio of generic oral liquid medicines in the industry, meeting the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities ...